November 8, 2021. Based on the data, we strongly support the “C” grade recommendation for patients 40 to 59 years old with a 10% or more risk of developing CVD, as well as the “D” grade recommendation for patients 60 and older. However, we urge the USPSTF to include additional information to their recommendation.
Read More »Tag: low dose aspirin
NCHR’s Comments to USPSTF on Aspirin to Prevent Morbidity and Mortality from Preeclampsia
March 22, 2021: We support this update, strengthened by new evidence, maintaining the 2014 “B” recommendation that there is moderate certainty of a substantial net benefit for the use of low-dose aspirin as preventive medication after 12 weeks of gestation in women who are at high risk for preeclampsia.
Read More »Can Daily Aspirin Prevent Both Heart Disease and Cancer?
Daily low-dose aspirin used to be widely recommended to prevent heart attacks but is now only recommended for patients who already have had heart attacks or other serious cardiovascular problems. It is not recommended for people with high blood pressure because it can cause serious bleeding complications that outweigh any benefits for heart disease or cancer. That’s why experts recommend safer options to help prevent heart disease in low-risk patients.
Read More »